Bristol Myers Squibb Says FDA Approves Heart Disease Treatment Camzyos for Pediatric Patients
Bristol-Myers Squibb Co BRM
News
Novo Inks Weight-Loss Licensing Deal With Hengrui Pharma
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths
Bristol Myers Squibb Gets FDA Approval for Myeloma Treatment
Cytokinetics Files Complaint on Patent Issue Against Bristol-Myers Squibb
Atrium Gets $15 Million in Latest Milestone Payment from Bristol Myers Squibb
Bristol Myers Squibb to Build $2.3 Billion Campus in Houston
An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it 'odd'
AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports — Update
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks
AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources
Bristol Myers Lifts Outlook as 2Q Profit, Revenue Rise
Bristol Myers Squibb to Advance AI Infrastructure in Collaboration with Nvidia
Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 — Data Talk
Bristol Myers Wins FDA Review of Mezigdomide in Multiple Myeloma
Arcus to Supply Experimental Kidney Cancer Drug for Myers Squibb Trial
Bristol-Myers Squibb on Pace for Largest Percent Decrease Since July 2025 — Data Talk
Bristol Myers Gets Speedy FDA Review of Camzyos in Adolescents
Bristol Myers Squibb and China's Hengrui Pharma Forge Tie-Up
Here's who benefits if the S&P 500 eases its rules for 'megacap' companies
United States